Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,584,226
-
Share change
-
-491,720
-
Total reported value
-
$37,073,960
-
Price per share
-
$14.35
-
Number of holders
-
17
-
Value change
-
-$5,592,430
-
Number of buys
-
7
-
Number of sells
-
9
Institutional Holders of TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) as of Q2 2014
As of 30 Jun 2014,
TONIX PHARMACEUTICALS HLDG C - COM NEW (TNXP) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,584,226 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, Broadfin Capital, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., BLUESTEIN R H & CO, Lombard Odier Asset Management (USA) Corp, WALL STREET ASSOCIATES, VANGUARD GROUP INC, SABBY MANAGEMENT, LLC, ORACLE INVESTMENT MANAGEMENT INC, and MORGAN STANLEY.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.